Conférences - Cancérologie - Allemagne

Der Hämato/Onko Refresher findet vom 08. - 09. November 2019 in Berlin statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Tél.: [+49 (0) 6192 957 89 41];     Email.: info@fomf.de

Hämatologie, Onkologie

Hématologie,    Formation médicale continue (FMC)

The 4th edition of this highly successful conference will focus on the latest advances in 3D-based cellular models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, high level imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking in order to develop approaches that translate to outcomes.

Tél.: [0115 951 5065];     Email.: roger.doxat-pratt@nottingham.ac.uk

cancer, oncology, research, cell adhesion, migration, mechanics, tumour invasion, 3D, in vitro, drug development, multicellular, immune, microenvironment, culture, mechanobiology

Group Futurista

Future of Personalized Medicine Summit for Oncology is a 2-day networking event with revolutionary keynotes, case studies, and panels. It brings together experts from the fields of Pharmaceutical, Biotechnology, Hospitals, and Academics to discuss how AI and Blockchain technologies are impacting the Future of Medicine. A one of a kind forum to benchmark, gain subject matter expertise & business intelligence by collaborating with industry leaders from the field of Engineering, Diagnostics, Bioinformatics, Drug Discovery, Therapies and more!

Email.: jennifer@groupfuturista.com

oncology events, personalized healthcare, precision medicine, precision oncology

Der Hämato/Onko Refresher findet vom 15. - 16. November 2019 in Stuttgart statt. In kurzen, 30 – 45 minütigen Vorträge werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Tél.: [+49 (0) 6192 957 89 41];     Email.: info@fomf.de

Hämatologie, Onkologie

Hématologie,    Formation médicale continue (FMC)

Der Hämato/Onko Refresher findet vom 29. - 30. November 2019 in Köln statt. In kurzen, 30 – 45 minütigen Vorträgen werden die neuesten diagnostischen und therapeutischen Leitlinien der Hämatologie und Onkologie von Spezialisten präsentiert und auf Ihre Fragen eingegangen. Dabei wird vor allem auf Praxisrelevanz großen Wert gelegt.

Forum für medizinische Fortbildung;     Tél.: [+49 (0) 6192 957 89 41];     Email.: info@fomf.de

Hämatologie, Onkologie

Hématologie,    Formation médicale continue (FMC)

Der DKK 2020 steht unter dem Motto informativ. innovativ. integrativ. Optimale Versorgung für alle.

Tél.: [+49 3643 2468-0];     Email.: info@kukm.de

German Cancer Reseach Center Heidleberg (DKFZ) and University Hospital Heidelberg

The fast technological development and the rapid clinical implementation of MRI for radiotherapy applications is currently one of the most exciting as well as most challenging developments in radiation oncology. With this science symposium we would not only like to bring together specialists from all involved disciplines, but also to foster a discussion about the scientific direction of the field. The latest developments in physics and technology of MR-guided radiotherapy as well as clinical directions and results will be presented.

Tél.: [+49 6221 423481];     Email.: mrinrthd@dkfz-heidelberg.de

MR guidance, image guidance, adaptive radiotherapy, MR imaging, functionall imaging and others

Biophysique,    Radiologie: Imagerie par résonance magnétique nucléaire

European Association for Cancer Research & European Society of Oncologic Imaging

This new conference is organised by the European Association for Cancer Research (EACR) and the European Society of Oncologic Imaging (ESOI).Our ability to understand and treat cancer is critically dependent upon imaging. This meeting will bring together imaging experts in both clinical and basic research arenas to present their latest research and discuss how to integrate understanding across length scales, imaging modalities, and cancer types. Improved clinical imaging has the power to transform the detection and biologic characterisation of early lesions and the identification of those patients with more advanced disease for tailoring and monitoring personalised therapies. Further, the development of new therapies depends on improved understanding of cancer biology; small animal imaging and imaging tumours with cellular and sub-cellular resolution can elucidate heterogeneity in cancer cell state and interactions with stromal cells, which provide new opportunities for therapeutic intervention. This conference is aimed at clinical and experimental cancer researchers working with, or interested in, the broad range of imaging modalities including US and photoacoustic, CT and micro CT, MRI, PET/CT and PET/MR hybrid imaging, as well as optical techniques. Data analysts dealing with imaging data science using deep learning/machine learning, are also explicitly encouraged to attend.

Email.: claire.sullivan@eacr.org

Imaging, Oncology, Machine Learning, Deep Learning, Cancer Biology, Personalised Therapies

Tél.: [+4936413116390];     Email.: conferencemarketing@conventus.de

Liquid biopsies have the advantage of being largely non-invasive and providing a vast amount of information for the detection and monitoring of diseases such as cancer. This course will provide hands-on experience in the several techniques to detect and analyse circulating tumor cells (CTCs), cell free tumor DNA (ctDNA) and proteins. Participants will have the opportunity to learn all aspects ranging from proper sampling through error free sequencing to data analysis. Lectures will also cover extracellular vesicles and clinical aspects using liquid biopsies, especially in the field of cancer diagnostics.

EMBL Events;     Tél.: [+49 6221 378 8797];     Email.: events@embl.de

Hands-on experience on ultra-sensitive mutation detection using sequencing, Applications of digital PCR to the liquid biopsy workflow, Protein analysis in liquid biopsis, Data analysis and interpretations

Médecine (en général),    Analyse

Tél.: [+4936413116390];     Email.: julia.wrenczycki@conventus.de